Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$3.79 - $8.3 $886 - $1,942
-234 Reduced 1.76%
13,059 $55,000
Q1 2023

May 04, 2023

SELL
$5.89 - $10.52 $1,390 - $2,482
-236 Reduced 1.74%
13,293 $90,000
Q4 2022

Feb 10, 2023

BUY
$5.69 - $10.07 $3,948 - $6,988
694 Added 5.41%
13,529 $107,000
Q3 2022

Nov 08, 2022

BUY
$7.17 - $13.87 $14,641 - $28,322
2,042 Added 18.92%
12,835 $123,000
Q2 2022

Aug 10, 2022

SELL
$5.86 - $13.23 $954,136 - $2.15 Million
-162,822 Reduced 93.78%
10,793 $78,000
Q1 2022

May 02, 2022

BUY
$10.92 - $16.41 $440,873 - $662,520
40,373 Added 30.3%
173,615 $2.24 Million
Q4 2021

Feb 03, 2022

SELL
$15.81 - $18.99 $14,592 - $17,527
-923 Reduced 0.69%
133,242 $2.13 Million
Q3 2021

Nov 10, 2021

SELL
$12.68 - $17.79 $35,846 - $50,292
-2,827 Reduced 2.06%
134,165 $2.16 Million
Q2 2021

Aug 06, 2021

SELL
$12.95 - $15.41 $59,052 - $70,269
-4,560 Reduced 3.22%
136,992 $1.9 Million
Q1 2021

May 13, 2021

SELL
$14.42 - $21.39 $96,657 - $143,377
-6,703 Reduced 4.52%
141,552 $2.07 Million
Q4 2020

Feb 12, 2021

BUY
$16.56 - $18.94 $853,684 - $976,375
51,551 Added 53.31%
148,255 $2.58 Million
Q3 2020

Nov 13, 2020

BUY
$17.41 - $19.89 $1.63 Million - $1.86 Million
93,751 Added 3174.77%
96,704 $1.77 Million
Q2 2020

Aug 06, 2020

BUY
$14.43 - $19.16 $42,611 - $56,579
2,953 New
2,953 $53,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $122M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.